Taikang Asset Management (Hong Kong) CO LTD Johnson & Johnson Transaction History

Taikang Asset Management (Hong Kong) CO LTD

$641 Million
Q2 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 07, 2019	SELL	$126.95 - $142.14 $679,690 - $761,017	-5,354 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$131.15 - $144.24 $702,045 - $772,116	-5,353 Reduced 50.0%	5,354 $746,000
Q4 2018 Feb 11, 2019	BUY	$122.84 - $147.84 $190,156 - $228,856	1,548 Added 16.9%	10,707 $1.38 Million
Q2 2018 Oct 29, 2018	BUY	$119.4 - $131.76 $304,589 - $336,119	2,551 Added 38.6%	9,159 $1.11 Million
Q1 2018 Oct 29, 2018	BUY	$125.1 - $148.14 $621,621 - $736,107	4,969 Added 303.17%	6,608 $847,000
Q4 2017 Oct 29, 2018	BUY	$131.22 - $143.62 $215,069 - $235,393	1,639	1,639 $229,000

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $419B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taikang Asset Management (Hong Kong) CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Taikang Asset Management (Hong Kong) CO LTD with notifications on news.

Account